Recently by Patrick H. Higgins
Current Prospects For A Generic Biopharmaceutical Industry
We are at a similar crossroads today with respect to generic biopharmaceuticals as we were in 1984 with respect to traditional pharmaceuticals. This article briefly reviews the fundamentals of market exclusivity in the drug-discovery industry and a series of rapidly evolving issues related to...
Read More